SCHEMBL4279652

SCHEMBL4279652

O=C(CS[Ag])Nc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
TSHR P16473 2/20 0.57
EPHX2 P34913 2/20 0.55
ALDH1A1 P00352 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 2/20 0.53
GAA P10253 1/20 0.53
NPC1 O15118 1/20 0.53
POLB P06746 1/20 0.53
HTT P42858 2/20 0.52
MAPT P10636 2/20 0.52
LMNA P02545 2/20 0.51
MAPK1 P28482 1/20 0.51
HPGD P15428 1/20 0.51
TP53 P04637 1/20 0.50
EPHX1 P07099 1/20 0.50
CDK9 P50750 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9126255 0.83 L3MBTL1 (0.72) SMN1; SMN2TSHREPHX2ALDH1A1L3MBTL1
SCHEMBL103220 0.80 TSHR (0.57) SMN1; SMN2TSHREPHX2ALDH1A1L3MBTL1
SCHEMBL7225647 0.80 TSHR (0.57) SMN1; SMN2TSHREPHX2ALDH1A1L3MBTL1
SCHEMBL6796256 0.78 ALDH1A1 (0.78) SMN1; SMN2TSHRALDH1A1L3MBTL1HSD17B10
SCHEMBL1689206 0.78 EPHX2 (0.68) SMN1; SMN2TSHREPHX2L3MBTL1KDM4E
SCHEMBL14242027 0.77 MAPT (0.70) SMN1; SMN2TSHRALDH1A1L3MBTL1HSD17B10
SCHEMBL13652653 0.77 HSD17B10 (0.67) SMN1; SMN2TSHRALDH1A1L3MBTL1HSD17B10
Ammonia Solution, Strong SCHEMBL28437729 0.77 ALDH1A1 (0.76) SMN1; SMN2TSHRALDH1A1L3MBTL1HSD17B10
SCHEMBL3342586 0.76 L3MBTL1 (0.80) SMN1; SMN2EPHX2ALDH1A1L3MBTL1KDM4E
SCHEMBL19841939 0.76 SMN1; SMN2 (0.58) SMN1; SMN2TSHREPHX2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10251392-B2 Antimicrobial devices and compositions AVENT, INC. (US) 2019-04-09 US disclosed
US-20090035342-A1 Antimicrobial Devices and Compositions AVANOS MEDICAL SALES, LLC 2009-02-05 US disclosed
EP-1781098-A2 ANTIMICROBIAL DEVICES AND COMPOSITIONS ACRYMED, INC. (US) 2007-05-09 EP disclosed
WO-2006015317-A2 ANTIMICROBIAL DEVICES AND COMPOSITIONS ACRYMED, INC. (US) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10251392-B2 Antimicrobial devices and compositions AAAS, AOC1, COL14A1 SMN1; SMN2 2723/4885TSHR 4664/4885EPHX2 3721/4885
US-20090035342-A1 Antimicrobial Devices and Compositions AAAS, AOC1, COL14A1 SMN1; SMN2 2723/4885TSHR 4664/4885EPHX2 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.